Tumors in the adenoma and epithelioma groups, which showed high AR and ER expression in the previous 2021 study, were subject to a significantly greater and faster reduction in diameter over the course of treatment when receiving antihormonal therapy compared to tumors in the carcinoma group. This evidence concerns the gene AR and adenoma.